These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 11162577)

  • 1. Functional analysis of mutant human carnitine acylcarnitine translocases in yeast.
    IJlst L; van Roermund CW; Iacobazzi V; Oostheim W; Ruiter JP; Williams JC; Palmieri F; Wanders RJ
    Biochem Biophys Res Commun; 2001 Jan; 280(3):700-6. PubMed ID: 11162577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular and functional analysis of SLC25A20 mutations causing carnitine-acylcarnitine translocase deficiency.
    Iacobazzi V; Invernizzi F; Baratta S; Pons R; Chung W; Garavaglia B; Dionisi-Vici C; Ribes A; Parini R; Huertas MD; Roldan S; Lauria G; Palmieri F; Taroni F
    Hum Mutat; 2004 Oct; 24(4):312-20. PubMed ID: 15365988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carnitine-acylcarnitine translocase deficiency: Two neonatal cases with common splicing mutation and in vitro bezafibrate response.
    Vatanavicharn N; Yamada K; Aoyama Y; Fukao T; Densupsoontorn N; Jirapinyo P; Sathienkijkanchai A; Yamaguchi S; Wasant P
    Brain Dev; 2015 Aug; 37(7):698-703. PubMed ID: 25459972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel mutations associated with carnitine-acylcarnitine translocase and carnitine palmitoyl transferase 2 deficiencies in Malaysia.
    Habib A; Azize NAA; Rahman SA; Yakob Y; Suberamaniam V; Nazri MIBA; Abdullah Sani H; Ch'ng GS; Yin LH; Olpin S; Lock-Hock N
    Clin Biochem; 2021 Dec; 98():48-53. PubMed ID: 34626609
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Carnitine-acylcarnitine translocase deficiency, clinical, biochemical and genetic aspects.
    Rubio-Gozalbo ME; Bakker JA; Waterham HR; Wanders RJ
    Mol Aspects Med; 2004; 25(5-6):521-32. PubMed ID: 15363639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Three novel mutations in the carnitine-acylcarnitine translocase (CACT) gene in patients with CACT deficiency and in healthy individuals.
    Fukushima T; Kaneoka H; Yasuno T; Sasaguri Y; Tokuyasu T; Tokoro K; Fukao T; Saito T
    J Hum Genet; 2013 Dec; 58(12):788-93. PubMed ID: 24088670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peroxisomes contribute to the acylcarnitine production when the carnitine shuttle is deficient.
    Violante S; Ijlst L; Te Brinke H; Koster J; Tavares de Almeida I; Wanders RJ; Ventura FV; Houten SM
    Biochim Biophys Acta; 2013 Sep; 1831(9):1467-74. PubMed ID: 23850792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expanded molecular features of carnitine acyl-carnitine translocase (CACT) deficiency by comprehensive molecular analysis.
    Wang GL; Wang J; Douglas G; Browning M; Hahn S; Ganesh J; Cox S; Aleck K; Schmitt ES; Zhang W; Wong LJ
    Mol Genet Metab; 2011 Aug; 103(4):349-57. PubMed ID: 21605995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carnitine-acylcarnitine translocase deficiency: identification of a novel molecular defect in a Bedouin patient.
    Galron D; Birk OS; Kazanovitz A; Moses SW; Hershkovitz E
    J Inherit Metab Dis; 2004; 27(2):267-73. PubMed ID: 15159657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of two novel mutations of the carnitine/acylcarnitine translocase (CACT) gene in a patient with CACT deficiency.
    Ogawa A; Yamamoto S; Kanazawa M; Takayanagi M; Hasegawa S; Kohno Y
    J Hum Genet; 2000; 45(1):52-5. PubMed ID: 10697964
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carnitine/acylcarnitine translocase deficiency (neonatal phenotype): successful prenatal and postmortem diagnosis associated with a novel mutation in a single family.
    Yang BZ; Mallory JM; Roe DS; Brivet M; Strobel GD; Jones KM; Ding JH; Roe CR
    Mol Genet Metab; 2001 May; 73(1):64-70. PubMed ID: 11350184
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Response to therapy in carnitine/acylcarnitine translocase (CACT) deficiency due to a novel missense mutation.
    Iacobazzi V; Pasquali M; Singh R; Matern D; Rinaldo P; Amat di San Filippo C; Palmieri F; Longo N
    Am J Med Genet A; 2004 Apr; 126A(2):150-5. PubMed ID: 15057979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective treatment in carnitine-acylcarnitine translocase deficiency.
    Pierre G; Macdonald A; Gray G; Hendriksz C; Preece MA; Chakrapani A
    J Inherit Metab Dis; 2007 Oct; 30(5):815. PubMed ID: 17508264
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional analysis of mutations in the human carnitine/acylcarnitine translocase in Aspergillus nidulans.
    Pérez P; Martínez O; Romero B; Olivas I; Pedregosa AM; Palmieri F; Laborda F; Ramón De Lucas J
    Fungal Genet Biol; 2003 Aug; 39(3):211-20. PubMed ID: 12892634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aberrant mRNA splicing associated with coding region mutations in children with carnitine-acylcarnitine translocase deficiency.
    Hsu BY; Iacobazzi V; Wang Z; Harvie H; Chalmers RA; Saudubray JM; Palmieri F; Ganguly A; Stanley CA
    Mol Genet Metab; 2001; 74(1-2):248-55. PubMed ID: 11592821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The structure and organization of the human carnitine/acylcarnitine translocase (CACT1) gene2.
    Iacobazzi V; Naglieri MA; Stanley CA; Wanders RJ; Palmieri F
    Biochem Biophys Res Commun; 1998 Nov; 252(3):770-4. PubMed ID: 9837782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mitochondrial carnitine-acylcarnitine translocase induced by partial hepatectomy and fasting.
    Sekoguchi E; Sato N; Yasui A; Fukada S; Nimura Y; Aburatani H; Ikeda K; Matsuura A
    J Biol Chem; 2003 Oct; 278(40):38796-802. PubMed ID: 12882971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. dif-1 and colt, both implicated in early embryonic development, encode carnitine acylcarnitine translocase.
    Oey NA; Ijlst L; van Roermund CW; Wijburg FA; Wanders RJ
    Mol Genet Metab; 2005 Jun; 85(2):121-4. PubMed ID: 15896656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carnitine-acylcarnitine translocase deficiency: case report and review of the literature.
    Rubio-Gozalbo ME; Vos P; Forget PP; Van Der Meer SB; Wanders RJ; Waterham HR; Bakker JA
    Acta Paediatr; 2003 Apr; 92(4):501-4. PubMed ID: 12801121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mouse carnitine-acylcarnitine translocase (CACT) is transcriptionally regulated by PPARalpha and PPARdelta in liver cells.
    Gutgesell A; Wen G; König B; Koch A; Spielmann J; Stangl GI; Eder K; Ringseis R
    Biochim Biophys Acta; 2009 Oct; 1790(10):1206-16. PubMed ID: 19577614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.